FDA Inspection
Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. – FDA Inspection, May 22, 2015
Record Details
This FDA Inspection record concerns Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd., with an inspection on May 22, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 22, 2015
- Product Type
- Drugs
View Company Profile
ID · cc2bb936-8bb9-4bcf-8a0f-84ef81171bff
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 931632
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | Not classified | Office of Inspections and Investigations | |
| June 14, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.